Your search for major depressive disorder returned 21 results

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

Researchers sought to evaluate the efficacy and safety of galcanezumab in patients with migraine in Japan.

Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

Migraine with active headache may predict other painful physical symptoms in patients with major depressive disorder.

Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.

The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

People with migraines and comorbid mood disorders often need treatments that address both conditions, as well as management of sleep, stress, and lifestyle issues.

Aerobic exercise may be associated with a reduction in the number of migraine days.

The findings suggest the importance of screening for posttraumatic stress disorder in this population.

A multi-faceted approach is best when treating pediatric headache.

In patients with migraine, structural and functional changes occur in brain regions that are not directly involved in processing pain signals.

Cyclic vomiting syndrome (CVS) and benign paroxysmal torticollis (BPT) during infancy are associated with a high risk for developing headache later in life.

In a systematic review, researchers examined the efficacy of digital headache management interventions for patients with a primary headache disorder.

Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.

A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.

An expert roundtable of headache specialists helps outline chronic migraine as its own entity, disparities and barriers to treatment, and a need for better research and education.

Acupuncture, neurostimulation, and other alternative treatments have been associated with up to a 50% reduction in headache days.

Lauren R. Natbony, MD, takes us on a deep dive into the association between nutrition and dietary patterns in migraine, including proposed mechanisms, and the remaining needs in patient education and research.